Cargando…
Synthesis and structure–activity relationship study of saponin-based membrane fusion inhibitors against SARS-CoV-2
We previously discovered that triterpenoid saponin platycodin D inhibits the SARS-CoV-2 entry to the host cell. Herein, we synthesized various saponin derivatives and established a structure–activity relationship of saponin-based antiviral agents against SARS-CoV-2. We discovered that the C3-glucose...
Autores principales: | Jang, Youngho, Young Kim, Tai, Jeon, Sangeun, Lim, Hyeonggeun, Lee, JinAh, Kim, Seungtaek, Justin Lee, C., Han, Sunkyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233891/ https://www.ncbi.nlm.nih.gov/pubmed/35809512 http://dx.doi.org/10.1016/j.bioorg.2022.105985 |
Ejemplares similares
-
Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion
por: Kim, Tai Young, et al.
Publicado: (2021) -
Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation
por: Kim, Tai Young, et al.
Publicado: (2022) -
Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay
por: Jang, Woo Dae, et al.
Publicado: (2021) -
Lancemaside A from Codonopsis lanceolata: Studies on Antiviral Activity and Mechanism of Action against SARS-CoV-2 and Its Variants of Concern
por: Kim, Tai Young, et al.
Publicado: (2022) -
TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)
por: Lee, Jihye, et al.
Publicado: (2021)